Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $51.45 USD
Change Today +2.43 / 4.96%
Volume 2.1M
ISIS On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 3:57 PM 08/27/15 All times are local (Market data is delayed by at least 15 minutes).

Key Executives - isis pharmaceuticals inc (ISIS)

NameBoard RelationshipsTitleAge
Stanley T. Crooke M.D., Ph.D.14 RelationshipsFounder, Executive Chairman, Chief Executive Officer, President, Chairman of Science/Medical Committee and Member of Agenda Committee70
Elizabeth L. Hougen No RelationshipsChief Financial Officer and Senior Vice President of Finance53
B. Lynne Parshall Esq., J.D.35 RelationshipsChief Operating Officer, Director and Member of Agenda Committee60
Kleanthis G. Xanthopoulos Ph.D.128 RelationshipsSenior Vice President, Chief Executive Officer of Regulus Therapeutics Inc and President of Regulus Therapeutics Inc57
C. Frank Bennett BSc, Ph.D.No RelationshipsSenior Vice President of Antisense Research58

Board Members - isis pharmaceuticals inc (ISIS)

NameBoard RelationshipsPrimary CompanyAge
Stanley T. Crooke M.D., Ph.D.14 RelationshipsIsis Pharmaceuticals, Inc.70
B. Lynne Parshall Esq., J.D.35 RelationshipsIsis Pharmaceuticals, Inc.60
Joseph Harris Wender 138 RelationshipsOutfront Media Inc.71
Spencer R. Berthelsen M.D.7 RelationshipsKS Management Services, LLC63
Frederick T. Muto J.D., Esq.7 RelationshipsCooley LLP62

Executive Committees* - isis pharmaceuticals inc (ISIS)

Committee NameChairpersonBoard RelationshipsMembers
Audit CommitteeJoseph Harris Wender 138 Relationships3 Executives
Compensation CommitteeSpencer R. Berthelsen M.D. 7 Relationships2 Executives
Nominating CommitteeSpencer R. Berthelsen M.D. 7 Relationships2 Executives
Corporate Governance CommitteeSpencer R. Berthelsen M.D. 7 Relationships2 Executives
View ISIS Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ISIS:US $51.47 USD +2.45

ISIS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
ACADIA Pharmaceuticals Inc $37.76 USD +1.38
Acorda Therapeutics Inc $31.66 USD -0.30
Alnylam Pharmaceuticals Inc $104.78 USD +2.53
Depomed Inc $28.80 USD +0.405
Impax Laboratories Inc $43.95 USD +0.52
View Industry Companies
 

Industry Analysis

ISIS

Industry Average

Valuation ISIS Industry Range
Price/Earnings 100.0x
Price/Sales 18.8x
Price/Book 19.6x
Price/Cash Flow 252.3x
TEV/Sales 14.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ISIS PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.